Atopic dermatitis displays stable and dynamic skin transcriptome signatures
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND Skin transcriptome studies in atopic dermatitis (AD) showed broad dysregulation as well as "improvement" under therapy. These observations were mainly made in trials and based on microarray data. OBJECTIVES To explore the skin transcriptome and the impact of systemic treatment in patients of the TREATgermany registry. METHODS Biopsies from 59 patients with moderate to severe AD before and 30 patients 12 weeks after start of systemic treatment (dupilumab n=22, cyclosporine n=8), and from 31 healthy controls were subjected to mRNA sequencing. Differential expression, pathway enrichment, correlation, and co-expression network analysis were conducted. RESULTS Both lesional and non-lesional skin showed a stable "core" signature characterised by disturbed epidermal differentiation and activation of IL31-IL1 signalling. A second dynamic signature showed progressive enrichment for type 2 inflammation, type 17 signalling and NK cell function. Markers correlated with disease activity have functions in epidermal barrier properties and immune modulation. IL4RA was among the top 3 central dysregulated genes. Cyclosporine led to a more pronounced global transcriptome reversion and normalised Th17/IL23 signalling, whereas dupilumab led to a stronger increase of epidermal differentiation markers. Both treatments strongly decreased type 2 markers, but overall the residual profile was still profoundly different from healthy skin. Lower IL4RA and IL13, and high IL36A expression were related to a stronger clinical response to dupilumab. CONCLUSION The AD core signature is characterised by dysregulation of genes related to keratinocyte differentiation and itch signalling. A dynamic signature reflects progressive immune responses dominated by type-2 cytokines with an additional role of type 17 and NK cell signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
RNA-Seq: a revolutionary tool for transcriptomics
Wang, Z., Gerstein, M., & Snyder, M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2484 · Cited by 13,174
Sequencing technologies – the next generation
Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066
RNA sequencing: advances, challenges and opportunities
Ozsolak, F., & Milos, P. M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2934 · Cited by 2,135
Weidinger, S., & Novak, N. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00149-x · Cited by 1,908
Self-citationWeidinger, S., Beck, L. A., Bieber, T., Kabashima, K., & Irvine, A. D. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0001-z · Cited by 1,549
Self-citationComputational methods for transcriptome annotation and quantification using RNA-seq
Garber, M., Grabherr, M. G., Guttman, M., & Trapnell, C. (2011) · Nature Methods · doi:10.1038/nmeth.1613 · Cited by 1,042
Gittler, J. K., Shemer, A., Suárez-Fariñas, M., Fuentes-Duculan, J., Gulewicz, K. J., Wang, C. Q. F., Mitsui, H., Cardinale, I., de Guzman Strong, C., Krueger, J. G., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.012 · Cited by 981
Tsoi, L. C., Rodriguez, E., Degenhardt, F., Baurecht, H., Wehkamp, U., Volks, N., Szymczak, S., Swindell, W. R., Sarkar, M. K., Raja, K., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.12.018 · Cited by 469
Self-citationEarly-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
Esaki, H., Brunner, P. M., Renert-Yuval, Y., Czarnowicki, T., Huynh, T., Tran, G., Lyon, S., Rodriguez, G., Immaneni, S., Johnson, D. B., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.013 · Cited by 428
Cited by
Novel insights into atopic dermatitis
Schuler, C. F., Billi, A. C., Maverakis, E., Tsoi, L. C., & Gudjonsson, J. E. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.10.023 · Cited by 281
Hashimoto, T., Yokozeki, H., Karasuyama, H., & Satoh, T. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.009 · Cited by 96
Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis
Humeau, M., Boniface, K., & Bodet, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801579 · Cited by 75
Martínez, B. A., Shrotri, S., Kingsmore, K. M., Bachali, P., Grammer, A. C., & Lipsky, P. E. (2022) · Science Advances · doi:10.1126/sciadv.abn4776 · Cited by 56
“More-over, because many of the widely used keratinocyte gene signatures were highly correlated with each other, ML analysis with these gene signatures previously reported in PSO and AD was not possible ( 30 , 68 , 69 ).”
Le Blay, H., Raynaud, E., Bouayadi, S., Rieux, E., Rolland, G., Saussine, A., Jachiet, M., Bouaziz, J., & Lynch, B. (2024) · Skin Research and Technology · doi:10.1111/srt.13891 · Cited by 12
Metadata
- Authors
- Möbus, L., Rodriguez, E., Harder, I., Stölzl, D., Boraczynski, N., Gerdes, S., Kleinheinz, A., Abraham, S., Heratizadeh, A., Handrick, C., Haufe, E., Werfel, T., Schmitt, J., & Weidinger, S.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 147
- Issue
- 1
- Pages
- 213-223
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W3039654485
- Cited by
- 133
- References
- 13
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.